Classify each ceftriaxone order by the neonatal medication-safety decision it supports.
Matrix
Choose your responses, then check the answer.
Explanation
Ceftriaxone is avoided in hyperbilirubinemic neonates and contraindicated in neonates who require calcium-containing intravenous solutions. Older infants still require allergy, dose, culture, and organ-function review but are not covered by the neonatal calcium prohibition.
Quick answer Screen neonatal bilirubin status and calcium-containing infusions before ceftriaxone.
Why this is correct Ceftriaxone can displace bilirubin from albumin and can precipitate with intravenous calcium in neonates, producing catastrophic organ deposits.
Easy analogy or mental picture Use a family-centered medication-safety loop: verify age or pregnancy context, identify the exposure and new cue, prevent further harm, stabilize the client, and confirm the response.
Memory hook Population, indication, dose or route, contraindication, urgent cue, protective action, and reassessment.
NCLEX decision rule Choose the action that protects the maternal, newborn, or pediatric client from the most immediate medication-related harm while preserving authorized treatment.
Why the other choices are wrong Options that normalize a danger sign, substitute an unapproved route or dose, or delay reassessment leave the client exposed to preventable harm.
References
1DailyMed: ceftriaxone for injectionContraindication in hyperbilirubinemic neonates and neonates requiring calcium-containing intravenous solutions
Maternal, newborn, and pediatric medication safety reviewVerify the client's age or pregnancy stage, indication, weight or laboratory context, route, interacting therapies, contraindications, caregiver teaching, and measurable follow-up.